| Indicators | Browse All

Fractyl Health, Inc. (GUTS)

Healthcare | Biotechnology | Burlington, United States | NasdaqGM
0.80 USD +0.04 (5.028%) ⇧ (July 14, 2026, 4 p.m. EDT)

Short-term:★★⯪☆☆Long-term:★☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 3:10 a.m. EDT

The immediate outlook remains murky despite a recent 77.6% drop over four weeks, which has created a technical bottom but offers no fundamental catalyst for a sustained rally. While the stock trades at a bargain price relative to its book value and analysts have issued strong buy ratings with targets significantly higher than the current level, these valuations are disconnected from reality given the company's burning cash pile and lack of profitability. The business is hemorrhaging free cash flow, and the balance sheet is precarious with debt nearly matching cash reserves, creating a high risk of dilution or distress before any clinical trial success can translate to revenue. Consequently, the short-term path is likely to remain choppy and volatile rather than trending decisively upward, while the long-term investment case is severely compromised by the inability to generate earnings or sustain operations without further capital raises.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.139466
AutoETS0.190718
AutoARIMA0.362607
MSTL0.448816

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 37%
H-stat 0.52
Ljung-Box p 0.000
Jarque-Bera p 0.745
Excess Kurtosis -0.44
Attribute Value
Sector Healthcare
Debt to Equity Ratio 284.497
Market Cap 126,919,168
Forward P/E -1.61
Beta 2.29
Website https://fractyl.com

Info Dump

Attribute Value
52 Week Change -0.5121951
Address1 3 Van de Graaff Drive
Address2 Suite 200
All Time High 14.5
All Time Low 0.377
Ask 0.9844
Ask Size 2
Average Analyst Rating 1.3 - Strong Buy
Average Daily Volume10 Day 809,140
Average Daily Volume3 Month 1,822,360
Average Volume 1,822,360
Average Volume10Days 809,140
Beta 2.287
Bid 0.5705
Bid Size 2
Book Value 0.135
City Burlington
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 0.8
Current Ratio 4.278
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 0.8226
Day Low 0.75
Debt To Equity 284.497
Display Name Fractyl Health
Earnings Call Timestamp End 1,778,617,800
Earnings Call Timestamp Start 1,778,617,800
Earnings Timestamp 1,778,616,000
Earnings Timestamp End 1,786,478,400
Earnings Timestamp Start 1,786,478,400
Ebitda -91,757,000
Ebitda Margins 0.0
Enterprise To Ebitda -1.358
Enterprise Value 124,568,168
Eps Current Year -0.39
Eps Forward -0.49833
Eps Trailing Twelve Months -1.31
Esg Populated 0
Exchange NGM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 0.7977
Fifty Day Average Change 0.002300024
Fifty Day Average Change Percent 0.0028833197
Fifty Two Week Change Percent -51.219513
Fifty Two Week High 2.445
Fifty Two Week High Change -1.645
Fifty Two Week High Change Percent -0.6728017
Fifty Two Week Low 0.377
Fifty Two Week Low Change 0.423
Fifty Two Week Low Change Percent 1.122016
Fifty Two Week Range 0.377 - 2.445
Financial Currency USD
First Trade Date Milliseconds 1,706,884,200,000
Float Shares 143,266,360
Forward Eps -0.49833
Forward P E -1.6053619
Free Cashflow -50,585,124
Full Exchange Name NasdaqGM
Full Time Employees 100
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Has Pre Post Market Data 1
Held Percent Insiders 0.01353
Held Percent Institutions 0.52417
Implied Shares Outstanding 158,648,963
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Ipo Expected Date 2,024-02-02
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. The company also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.
Long Name Fractyl Health, Inc.
Market us_market
Market Cap 126,919,168
Market State PRE
Max Age 86,400
Message Board Id finmb_154091089
Most Recent Quarter 1,774,915,200
Net Income To Common -108,001,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 126,919,170
Number Of Analyst Opinions 6
Open 0.7617
Operating Cashflow -87,726,000
Operating Margins 0.0
Payout Ratio 0.0
Phone 781 902 8800
Pre Market Change 0.050000012
Pre Market Change Percent 6.250001
Pre Market Price 0.85
Pre Market Time 1,784,116,075
Previous Close 0.76170003
Price Eps Current Year -2.0512822
Price Hint 4
Price To Book 5.9259257
Profit Margins 0.0
Quick Ratio 4.1
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key strong_buy
Recommendation Mean 1.28571
Region US
Regular Market Change 0.0383
Regular Market Change Percent 5.02822
Regular Market Day High 0.8226
Regular Market Day Low 0.75
Regular Market Day Range 0.75 - 0.8226
Regular Market Open 0.7617
Regular Market Previous Close 0.76170003
Regular Market Price 0.8
Regular Market Time 1,784,059,200
Regular Market Volume 1,377,360
Return On Assets -0.63641
Return On Equity -7.78329
Sand P52 Week Change 0.2043345
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 158,648,963
Shares Percent Shares Out 0.0146
Shares Short 2,314,245
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 2,412,445
Short Name Fractyl Health, Inc.
Short Percent Of Float 0.0156
Short Ratio 1.37
Source Interval 15
State MA
Symbol GUTS
Target High Price 8.0
Target Low Price 2.0
Target Mean Price 5.03333
Target Median Price 5.1
Total Cash 63,168,000
Total Cash Per Share 0.398
Total Debt 60,817,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1.31
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 1.079585
Two Hundred Day Average Change -0.27958494
Two Hundred Day Average Change Percent -0.25897446
Type Disp Equity
Volume 1,377,360
Website https://fractyl.com
Zip 1,803